Skip to main content
. 2020 Jun 22;12(12):11864–11877. doi: 10.18632/aging.103357

Figure 6.

Figure 6

KEGG Enrichment and therapeutic targets of ADCYs in AML. (A) Significant terms among the gene memberships (Metascape). (B) KEGG analysis of FANGs in AML. (C) Protein-drug interaction map for inhibitors of the MAPK pathway in AML.